Limited Edition Golden Llama is here! Check out how you can get one.
Limited Edition Golden Llama is here! Check out how you can get one.
Offering SPR-BLI Services - Proteins provided for free!
Offering SPR-BLI Services - Proteins provided for free!
Here come GMP Grade Cytokines!Free Sample is available!
Here come GMP Grade Cytokines!Free Sample is available!
Human IL-12 R beta 1, Fc Tag (Cat. No. ILB-H5255) captured on CM5 chip via Anti-human IgG Fc antibodies surface can bind Human IL-12B&IL-12A Heterodimer Protein, His Tag&Flag Tag (Cat. No. IL2-H4210) with an affinity constant of 2.06 nM as determined in a SPR assay (Biacore T200) (Routinely tested).
Name | Research Code | Research Phase | Company | First Brand Name | First Approved Country | First Indication | First Approved Company | First Approved Date | Indications | Clinical Trials |
---|---|---|---|---|---|---|---|---|---|---|
Ustekinumab biosimilar (Samsung Bioepis) | SB-17; SB17 | Approved | Samsung Bioepis Co Ltd | Pyzchiva | EU | Crohn Disease; Colitis, Ulcerative | Samsung Bioepis Nl Bv | 2024-04-19 | Gastrointestinal Diseases; Skin Diseases; Psoriasis; Colitis, Ulcerative; Arthritis, Psoriatic; Rheumatic Diseases; Inflammation; Crohn Disease; Plaque psoriasis | Details |
Name | Research Code | Research Phase | Company | Indications | Clinical Trials |
---|---|---|---|---|---|
KLT-1101 | KLT-1101 | Phase 2 Clinical | Kang Litai Pharmaceutical Co Ltd | Solid tumours; Leukopenia; Thrombocytopenia; Melanoma; Sarcoma, Kaposi | Details |
Edodekin alfa | RO 247472; YM 01C | Phase 2 Clinical | Wistar Institute, Valeant, F. Hoffmann-La Roche Ltd | Hepatitis B; Melanoma; Bacterial Infections; Sarcoma, Kaposi; Leishmaniasis; Carcinoma, Squamous Cell; Lymphoma, T-Cell, Cutaneous; Lymphoma, Non-Hodgkin; Lymphoma; Asthma; Hepatitis C; Solid tumours; Breast Neoplasms; Neoplasms; Carcinoma, Ovarian Epithelial; Graft vs Host Disease; Squamous Cell Carcinoma of Head and Neck; Abdominal Neoplasms; Carcinoma, Renal Cell; Malaria; HIV Infections | Details |
IMNN-001 | IMNN-001; phIL-12-005/PPC; GEN-1; EGEN-001 | Phase 2 Clinical | Expression Genetics | Cystadenocarcinoma; Ovarian Neoplasms; Cystadenocarcinoma, Serous; Carcinoma, Ovarian Epithelial; Colorectal Neoplasms; Peritoneal Neoplasms; Fallopian Tube Neoplasms; Carcinoma, Endometrioid | Details |
RTX-224 | RTX-224 | Phase 2 Clinical | Rubius Therapeutics Inc | Solid tumours; Skin Melanoma; Squamous Cell Carcinoma of Head and Neck; Carcinoma, Transitional Cell; Triple Negative Breast Neoplasms; Carcinoma, Non-Small-Cell Lung | Details |
SON-1010 | SON-1010 | Phase 2 Clinical | Sonnet Biotherapeutics Inc | Solid tumours; Carcinoma, Ovarian Epithelial; Peritoneal Neoplasms; Fallopian Tube Neoplasms | Details |
KB-707 | KB707; KB-707 | Phase 2 Clinical | Krystal Biotech Inc | Solid tumours; Skin Melanoma; Neoplasms; Lung Neoplasms; Melanoma; Carcinoma, Non-Small-Cell Lung | Details |
ASP-9801 | ASP-9801 | Phase 1 Clinical | Astellas Pharma Inc | Solid tumours; Neoplasms; Neoplasm Metastasis | Details |
ANK-101 | ANK101; ANK-101 | Phase 1 Clinical | Ankyra Therapeutics Inc | Solid tumours; Soft Tissue Injuries; Skin Neoplasms; Carcinoma, Squamous Cell; Carcinoma, Non-Small-Cell Lung | Details |
CLN-617 | CLN-617 | Phase 1 Clinical | Cullinan Therapeutics Inc | Solid tumours | Details |
phIL12 GET | Phase 1 Clinical | Institute Of Oncology Ljubljana | Carcinoma, Basal Cell | Details | |
Encapsulated pancreatic cancer vaccine(Therapyx) | PCX-12 | Phase 1 Clinical | TherapyX Inc | Pancreatic Neoplasms | Details |
This web search service is supported by Google Inc.